Last reviewed · How we verify
Western Medicine
Western medicine works by targeting the immune system to treat various conditions.
Western medicine works by targeting the immune system to treat various conditions. Used for Metastatic non-small cell lung cancer, Multiple myeloma.
At a glance
| Generic name | Western Medicine |
|---|---|
| Also known as | intra-nasal corticosteroid(AVAMYS) with Montelukast (singulair), WM, Ribavirin, |
| Sponsor | Chang Gung Memorial Hospital |
| Drug class | Immunomodulator |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
Western medicine is a broad term that encompasses various treatments and therapies, but in this case, it likely involves the use of immunomodulatory agents to modulate the immune response and treat diseases such as cancer or autoimmune disorders.
Approved indications
- Metastatic non-small cell lung cancer
- Multiple myeloma
Common side effects
- Fatigue
- Nausea
- Diarrhea
Key clinical trials
- Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance (NA)
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) (PHASE2)
- User Testing of an End of Life Medication Support Intervention for Lay Carers (Palliate). (NA)
- Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics (NA)
- Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial) (PHASE2)
- Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) (PHASE2)
- Mobile Vehicle-Based Delivery of Lenacapavir PrEP in Los Angeles County
- Physical Impairments in Premature Ventricular Complex
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |